logo

Exhibiting at Middle East Poultry Expo 2025

H22
RICEC, Riyadh
14 Apr - 16 Apr, 2025

Product Offerings

Products:

Active Pharmaceutical Ingredients (APIs): Spectinomycin HCl/Sulfate, Tylosin Tartrate, Flunixin Meglumine, Tylosin Base, Tilmicosin Base/Phosphate, Tulathromycin, Tiamulin Fumarate, Ceftiofur Sodium/HCl, Ceftriaxone Sodium, Cefazolin Sodium

Veterinary Drugs: Flunixin Meglumine, Tulathromycin, Tylosin, Spectinomycin

Finished Dosage Forms (FDFs): Capsules, Tablets, Dispersible Tablets, Powder Injections, Granules, Dry Suspensions, Water Injections, Premixes, Compound Preparations

Biopesticides: Bacillus Thuringiensis, Spinosad, Gibberellin

Shandong Lukang Pharmaceutical Co., Ltd., located in Jining, China, is one of the country's foremost pharmaceutical manufacturers and exporters, renowned for its comprehensive range of Active Pharmaceutical Ingredients (APIs), finished dosage formulations, veterinary medicines, and biopesticides. With a strong foundation rooted in innovation, compliance, and global trade, Lukang is a key player in China’s bio-pharmaceutical landscape.

Core Business and Product Offerings

Shandong Lukang’s product suite spans multiple healthcare domains with a diversified manufacturing base. Key product categories include:

  • Active Pharmaceutical Ingredients (APIs)

    • Spectinomycin HCl/Sulfate
    • Tylosin Tartrate
    • Flunixin Meglumine
    • Tylosin Base
    • Tilmicosin Base/Phosphate
    • Tulathromycin
    • Tiamulin Fumarate
    • Ceftiofur Sodium/HCl
    • Ceftriaxone Sodium
    • Cefazolin Sodium
  • Finished Dosage Forms (FDFs)

    • Capsules
    • Tablets
    • Dispersible Tablets
    • Powder and Water Injections
    • Granules
    • Dry Suspensions
    • Premixes and Compound Preparations
  • Veterinary Drugs

    • Antimicrobials: Tylosin, Spectinomycin
    • Anti-inflammatory: Flunixin Meglumine
    • Macrolides: Tulathromycin
  • Biopesticides

    • Bacillus Thuringiensis (Bt)
    • Spinosad
    • Gibberellin

These products cater to global human health, animal health, and agrochemical markets with an emphasis on innovation and regulatory compliance.

Specialisation and Core USP

Lukang Pharmaceutical is recognized for its vertically integrated production model and its dual focus on human and animal health. Distinct strengths include:

  • World-class fermentation technology for antibiotic APIs
  • Advanced formulation facilities for both oral and injectable dosage forms
  • In-house synthesis of key intermediates for supply chain control
  • Emphasis on biopharmaceutical innovation and ecological agro-solutions

Financials and Scale of Operations

Although specific financial data for the privately managed entity is limited, Shandong Lukang has been acknowledged as:

  • One of the top 100 pharmaceutical manufacturers in China
  • Exporter to over 50 countries, with strong presence in Asia, South America, and Africa
  • Operator of multiple GMP-certified manufacturing sites, covering over 1 million square meters

International Shipments

According to data from global trade databases and export tracking:

  • Key Export Markets: India, Egypt, Vietnam, Mexico, Brazil, Pakistan
  • Top Products Shipped: Spectinomycin, Tylosin Tartrate, Tulathromycin, injectable formulations
  • Estimated Export Volume: 1,500+ consignments annually
  • Registration Status: Holds multiple DMFs (Drug Master Files) in the US, EU, and other regulated markets

Target Markets

Shandong Lukang’s target clientele includes:

  • Human pharmaceutical companies requiring API sourcing
  • Veterinary medicine producers
  • Generic drug manufacturers
  • Agrochemical companies and pesticide distributors

Its dual regulatory strategy enables the company to cater to both regulated and semi-regulated markets efficiently.

Capabilities

  • Multiple GMP-compliant production lines
  • Dedicated R&D centers for antibiotic synthesis and formulation development
  • Pilot scale labs for scale-up and new drug delivery systems
  • International logistics and compliance teams for DMF/CEP support

The company also collaborates with national and international universities and research institutes for technology transfer and clinical studies.

Certifications and Compliance

Shandong Lukang maintains rigorous compliance standards, including:

  • GMP Certification (China FDA, US FDA-inspected)
  • CEP Certification (EDQM)
  • ISO9001, ISO14001, OHSAS18001
  • Veterinary GMP Licenses for veterinary drug production
  • REACH and RoHS compliance for agrochemical exports

These certifications affirm their manufacturing excellence and regulatory discipline.

Customer Testimonials

Though direct testimonials are limited, the sustained presence of Lukang in highly regulated markets and its partnerships with multinational pharma companies are indicative of its performance and reliability.

Major Achievements

  • Recognized by China's Ministry of Industry and Information Technology as a Key Antibiotic API Exporter
  • Developer of proprietary fermentation and macrolide antibiotic production technologies
  • Winner of provincial innovation awards in biotechnology
  • Successfully filed DMFs in the US, Europe, and Japan for key antibiotic APIs

Shandong Lukang Pharmaceutical Co., Ltd. continues to drive forward with its mission to advance health and wellness through robust pharmaceutical manufacturing and sustainable bio-solutions.